This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1056/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q68815180
rdf:type
wikibase:Item
schema:description
article scientifique publié en 1987 наукова стаття, опублікована у квітні 1987 wetenschappelijk artikel artículu científicu espublizáu n'abril de 1987 im April 1987 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 April 1987
p:P577
wds:Q68815180-F486A2EF-8A8E-48EA-9C70-116670D83D80
wdt:P577
1987-04-01T00:00:00Z
p:P2093
wds:Q68815180-5241B0EB-3C43-4D05-963D-A3A4F999C3DC wds:Q68815180-244A038B-F1D7-4C4D-941C-B07ECE1C22DB wds:Q68815180-EFEFE4DC-3E75-4F4C-8285-FB438BBCA091 wds:Q68815180-D1C6727D-7CF0-45A1-A0FC-3B7C9E5785DB wds:Q68815180-820157C9-563A-4454-ADB2-4E9059BE0DB2 wds:Q68815180-A767F382-0AD0-414D-B9C3-B948359789E3 wds:Q68815180-FCEBDCC6-CC8A-41DC-BDB3-AAC3D2AAA45E wds:Q68815180-156EC1A2-0505-4B3A-8468-513D7B9E0BC0
wdt:P2093
Rubin JT Avis FP Linehan WM Lee RE Leitman S Robertson CN Muul LM Chang AE
rdfs:label
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
skos:prefLabel
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
schema:name
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
p:P50
wds:Q68815180-F461CE65-C1A3-45EE-B5D2-AC8FD2D10B43 wds:Q68815180-FAB5470D-EB5B-46E7-B045-68F18F36FF9A
wdt:P50
wd:Q89121415 wd:Q2347448
p:P1476
wds:Q68815180-5E26DA7A-7B59-442F-8D02-AFEDB9380FF8
wdt:P1476
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
p:P304
wds:Q68815180-A9C8686B-D6C1-4B65-A666-BF492C216671
wdt:P304
889-897
p:P31
wds:Q68815180-2DA67058-7A87-4319-B606-50C0E1552D0F
wdt:P31
wd:Q13442814
p:P698
wds:Q68815180-352C67E6-10B7-465A-BE27-1ED4E3D2880D
wdtn:P698
n10:3493432
wdt:P698
3493432
p:P1433
wds:Q68815180-1E34AC93-6C92-4D0C-AA80-8F0F70B444F8
wdt:P1433
wd:Q582728
p:P433
wds:Q68815180-5B210FF2-97CB-4C82-ACBF-A27FC56B4DE7
p:P478
wds:Q68815180-4C9D47E6-6C23-40FE-BAE1-5C50291D115E
wdt:P433
15
wdt:P478
316
p:P356
wds:Q68815180-F53E02E6-2AB7-40B9-A771-4B82C2A9A7E7
wdtn:P356
n11:NEJM198704093161501
wdt:P356
10.1056/NEJM198704093161501